Literature DB >> 7239323

Effect of nitrates on LOS pressure in achalasia: a potential therapeutic aid.

M Gelfond, P Rozen, S Keren, T Gilat.   

Abstract

The effect of a long-acting nitrate, isosorbide dinitrate (ID) 5 mg sublingually, on the lower oesophageal sphincter was tested in 24 patients with achalasia. The drug caused a reduction in LOS pressure in all cases. The mean LOS pressure fell from 46.32.7 mmHg to 15.31.8 mmHg (p less than 0.01). The pressure began to drop after several minutes, reaching its lowest levels after 15 minutes. This measured manometric effect lasted for 60 minutes or more in 10 patients studied. The reported clinic effect lasted for two to three hours, permitting the ingestion of a meal. Twenty-three patients were followed clinically for two to 19 months while receiving the drug three times daily before meals. Nineteen reported a marked to complete relief of dysphagia. Five of these patients had previous pneumatic dilatation, cardiomyotomy, or both, and had recurrence at time of study. Side-effect, mainly headache, were reported in eight patients. In six this was alleviated by substituting oral isosorbide dinitrate, 10 mg. Two patients became refractory to treatment after two to six months. The potential role of long-acting nitrates in the treatment of achalasia has yet to be established.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7239323      PMCID: PMC1419164          DOI: 10.1136/gut.22.4.312

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  17 in total

1.  Effects of drugs on esophageal motility.

Authors:  J Christensen
Journal:  Arch Intern Med       Date:  1976-05

2.  MANOMETRIC STUDIES IN ACHALASIA OF THE CARDIA, BEFORE AND AFTER PNEUMATIC DILATIONS.

Authors:  G VANTRAPPEN; G E VANGOIDSENHOVEN; S VERBEKE; G VANDENBERGHE; J VANDERBROUCKE
Journal:  Gastroenterology       Date:  1963-09       Impact factor: 22.682

3.  Roentgen studies of esophageal transport in patients with dysphagia due to abnormal motor function.

Authors:  S H LORBER; H SHAY
Journal:  Gastroenterology       Date:  1955-05       Impact factor: 22.682

4.  Management of achalasia in infancy and childhood.

Authors:  S F REDO; C H BAUER
Journal:  Surgery       Date:  1963-02       Impact factor: 3.982

5.  Buscopan and oesophageal achalasia.

Authors:  J T WRIGHT
Journal:  Br J Radiol       Date:  1961-02       Impact factor: 3.039

6.  An uncontrolled comparison of treatments for achalasia.

Authors:  J Yon; J Christensen
Journal:  Ann Surg       Date:  1975-12       Impact factor: 12.969

7.  Clinical and manometric effects of nitroglycerin in diffuse esophageal spasm.

Authors:  R C Orlando; E M Bozymski
Journal:  N Engl J Med       Date:  1973-07-05       Impact factor: 91.245

8.  Achalasia: results of operation in 84 patients.

Authors:  J R Rees; B Thorbjarnarson; W H Barnes
Journal:  Ann Surg       Date:  1970-02       Impact factor: 12.969

Review 9.  Nitroglycerin and nitrate esters.

Authors:  S E Warren; G S Francis
Journal:  Am J Med       Date:  1978-07       Impact factor: 4.965

10.  Results of Heller's operation for achalasia of the oesophagus. The importance of hiatal repair.

Authors:  J Black; A N Vorbach; J L Collis
Journal:  Br J Surg       Date:  1976-12       Impact factor: 6.939

View more
  18 in total

Review 1.  Pharmacotherapy for the management of achalasia: Current status, challenges and future directions.

Authors:  Ammar Nassri; Zeeshan Ramzan
Journal:  World J Gastrointest Pharmacol Ther       Date:  2015-11-06

2.  Treatment of esophageal achalasia with Heller myotomy: retrospective evaluation of patient satisfaction and disease-specific quality of life.

Authors:  Yen Dang; Dale Mercer
Journal:  Can J Surg       Date:  2006-08       Impact factor: 2.089

3.  Treatment of esophageal motility disorders based on the chicago classification.

Authors:  Carla Maradey-Romero; Scott Gabbard; Ronnie Fass
Journal:  Curr Treat Options Gastroenterol       Date:  2014-12

Review 4.  Therapeutic options in oesophageal dysphagia.

Authors:  Jan Tack; Giovanni Zaninotto
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2015-03-31       Impact factor: 46.802

Review 5.  Rational pharmacotherapy of gastrointestinal motility disorders.

Authors:  P Demol; H J Ruoff; T R Weihrauch
Journal:  Eur J Pediatr       Date:  1989-04       Impact factor: 3.183

Review 6.  Nitrates for achalasia.

Authors:  Z H Wen; E Gardener; Y P Wang
Journal:  Cochrane Database Syst Rev       Date:  2004

7.  The cost-effectiveness of treatment strategies for achalasia.

Authors:  J Barry O'Connor; Mendel E Singer; Thomas F Imperiale; Michael F Vaezi; Joel E Richter
Journal:  Dig Dis Sci       Date:  2002-07       Impact factor: 3.199

Review 8.  The surgical management of motility disorders.

Authors:  H Feussner; W Kauer; J R Siewert
Journal:  Dysphagia       Date:  1993       Impact factor: 3.438

Review 9.  The chronic gastrointestinal manifestations of Chagas disease.

Authors:  Nilce Mitiko Matsuda; Steven M Miller; Paulo R Barbosa Evora
Journal:  Clinics (Sao Paulo)       Date:  2009       Impact factor: 2.365

Review 10.  A controversy that has been tough to swallow: is the treatment of achalasia now digested?

Authors:  Garrett R Roll; Charlotte Rabl; Ruxandra Ciovica; Sofia Peeva; Guilherme M Campos
Journal:  J Gastrointest Surg       Date:  2009-09-17       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.